BNET Industries

MTS Medication Technologies Inc.

(MPP) is in the Manufacturing Industry

Last Fiscal Year Sales:$57.8M
  • Public
  • US
Dow Jones Description

We were incorporated in Delaware in March 1984. We are a holding company that operates through our subsidiaries, MTS Packaging Systems, Inc. (MTSP), MTS Medication Technologies, Ltd. (MTS Limited), BAF Printers, Ltd. (BAF) and MTS Medication Technologies GmbH (MTS GmbH). BAF and MTS GmbH are wholly owned subsidiaries of MTS Limited. MTS primarily manufactures and sells consumable medication punch cards, packaging equipment and ancillary products throughout the United States (the U.S.), Canada and Europe. Our customers are predominantly institutional pharmacies that supply nursing homes, assisted living and correctional facilities with prescription medications for their patients. MTS manufactures its proprietary consumable punch cards and most of our packaging equipment in our own facilities. This manufacturing process uses integrated equipment for manufacturing the consumable medication punch cards. In addition, we utilize the services of outside contract manufacturers for some of our packaging equipment. The consumable medication punch cards and packaging equipment are designed to provide a cost effective method for pharmacies to dispense medications. MTSs medication dispensing systems and products provide innovative methods for dispensing medications in disposable packages. MTS Limited distributes products for MTS primarily in the United Kingdom (the U.K.). BAF manufactures and sells prescription bags and labels in the U.K. MTS GmbH distributes products for MTS in Germany. ...

Chairman of The Board, President and Chief Executive OfficerTodd E. Siegel
Number of Employees 236
Contact Information

2003 Gandy Blvd.

Suite 800

St. Petersburg, Florida 33702

mts-mt.com

(800) 671-0508

NAICS Code Packaging Machinery Manufacturing: 333993

Recent Events

  • MTS Medication Tech. MTSI Tops Q4 Views

    6/16/09 - Financial Announcement - View Story

  • MTS Medication Technologies, Inc. Announces Third Quarter and Nine-Month Financial Results

    2/17/09 - Financial Announcement - View Story

News & Analysis

Filter by

mts medication technologies inc. - All News and Analysis

Additional Resources

  • MTS Reports Financial Results for 4Q and Fiscal Year

    - 2009-06-19

    Wireless News06-19-2009MTS Reports Financial Results for 4Q and Fiscal YearType: NewsMTS Medication Technologies, Inc., an international provider of medication adherence packaging systems, announced its financial results for its fourth quarter and year ended March 31. The company reported in a June 16 release that revenue for the fourth quarter...

  • MTS Announces Financial Results for Fourth Quarter and Fiscal Year Ended March 31, 2009

    - 2009-06-16

    Revenue up 32% - EPS up 19% for the Year Provides General Business Update ST. PETERSBURG, Fla. -- MTS...

  • MTS Medication Technologies to Host 4Q Conference Call

    - 2009-06-12

    Wireless News06-12-2009MTS Medication Technologies to Host 4Q Conference CallType: NewsMTS Medication Technologies announced that it will release its fourth quarter and year-end results for the period ended March 31, before the market opens on Tuesday, June 16. Management of the company will host a conference call on that day...

Decision Makers

Name (plus bio) Position
Michael Branca CFO
Michael D. Stevenson COO & Vice President, Finance
Michael P. Conroy Vice President and Chief Financial Officer Exhibit Index
Joshua B. Sinsley Vice President, Business Development
Perry W. Larson Vice President, Sales and Marketing
Peter M. Benjamin Vice President, HR
Peter T. Gilbert Vice President, Marketing
Ron Rosenbaum Vice President, Technology
Peter A. Williams Managing Director, Subsidiary
Tammy Leon Manager, HR
James M. Conroy Controller
Terri Dunbar Controller
Michael Conroy James Principal Accounting Officer
Irv Cohen Director

Board of Directors

Name (plus bio) Position
Todd E. Siegel Chairman of The Board, President and Chief Executive Officer
Allen S. Braswell Board of Directors
Chet Borgida Board of Directors
David W. Kazarian Board of Directors
Edgardo A. Mercadante Board of Directors
Frank A. Newman Board of Directors
John Stanton Vice Chairman

Todd E. Siegel. Mr. Siegel became our President and Chief Executive Officer in 1992 and has served as a director of MTS since 1986. Mr. Siegel served from 1988 to 1992 as Executive Vice President and Chief Operating Officer of MTS and from 1985 to 1988 as Vice President of Sales. Additionally, Mr. Siegel served as our Secretary from 1986 to 1996. See Certain Transactions and Employment Agreements. Mr. Siegel currently serves as the President of the Golda Meir/Kent Jewish Center, the Vice President of Finance of Temple B nai Israel and a director of Halo, Inc. and Applied Magnetics, LLC, both privately owned companies.

Organization Position Status
MTS Medication Technologies Chairman of The Board, President and Chief Executive Officer Current
MTS Medication Technologies Director Current
MTS Medication Technologies Chief Operating Officer Former
MTS Medication Technologies Executive Vice President Former
Organization Position Status
MTS Medication Technologies CFO Current
Organization Position Status
MTS Medication Technologies COO & Vice President, Finance Current

Michael P. Conroy serves as our Chief Financial Officer and his son, James M. Conroy, serves as our Controller. Because of the family relationship among these members of our management, certain employer/employee matters may not be conducted on a fully arms-length basis as would be the case if the family relationship did not exist. However, independent directors unrelated to the Conroy family comprise our Compensation Committee and Audit Committee and we expect that compensation and other significant employer/employee issues, including performance evaluations and compensation reviews, will be conducted on a fully arms-length basis as would be the case if the family relationship did not exist.

Organization Position Status
MTS Medication Technologies Vice President and Chief Financial Officer Exhibit Index Current
MTS Medication Technologies Board of Directors Current
Organization Position Status
MTS Medication Technologies Vice President, Business Development Current

Perry W. Larson. Mr. Larson has been our Vice President, Sales and Marketing since April 2005. From October 2004 to April 2005, he was our Director of Sales. From April 2003 to October 2004, Mr. Larson was the Director of Sales for Financial Resources of America. From August 1999 to April 2003, Mr. Larson was a LTC Specialist for Farmers Group, Inc.

Organization Position Status
MTS Medication Technologies Vice President, Sales and Marketing Current
Financial Resources Director of Sales Former
Farmers Group, Inc. Ltc Specialist Former
Organization Position Status
MTS Medication Technologies Vice President, HR Current
Organization Position Status
MTS Medication Technologies Vice President, Marketing Current
Organization Position Status
MTS Medication Technologies Vice President, Technology Current

Peter A. Williams. Mr. Williams has been the Managing Director of MTS Medication Technologies, Ltd. ( MTS Limited ) since September 2003. Mr. Williams was a Consultant Pharmacist to MTS from 2000 to 2003.

Organization Position Status
MTS Medication Technologies Managing Director, Subsidiary Current
Organization Position Status
MTS Medication Technologies Manager, HR Current

James M. Conroy. Mr. Conroy has served as our Controller since February 2008. From June 2006 to October 2007, Mr. Conroy served as Managing Partner of Conroy & Febo, CPAs, a Florida accounting firm. From June 2005 to June 2006, Mr. Conroy served as Manager of Corporate Accounting for Starwood Vacation Ownership, a vacation ownership company that acquires, develops and markets resort communities throughout the world. From April 2001 to June 2005, Mr. Conroy served as Director, Finance and Controller of Ultimate Franchise Systems, Inc., a franchisor of quick service and casual dining restaurants. Mr. Conroy received a B.S.B.A. degree in accounting from the University of Central Florida and is an active Certified Public Accountant in the State of Florida.

Organization Position Status
MTS Medication Technologies Controller Current
Starwood Vacation Ownership Manager Former
University of Central Florida B.S.B.A. Degree In Accounting Former
Organization Position Status
MTS Medication Technologies Controller Current
Organization Position Status
MTS Medication Technologies Principal Accounting Officer Current

Allen S. Braswell. Mr. Braswell has served as a director of MTS since 2005. Since 2007, Mr. Braswell has been the President of Pico-Tesla Magnetic Therapies, LLC. Mr. Braswell has been a member of the Board of Directors of Suntron Corp. since 1998, and has served on its audit and governance committees and as chairman of a special committee representing minority stockholders in matters related to an earlier merger. Prior to 1998, he was President of Jabil Global Services, Vice President of EFTC Services, President/CEO of Circuit Test Inc. and an attorney in practice with Tanney, Ford, Donahey, Eno and Mills, P.A. Mr. Braswell attended the U.S. Military Academy (West Point) and graduated from the University of Florida with a bachelor s degree in finance. He received his J.D. degree from University of Florida School of Law.

Organization Position Status
MTS Medication Technologies Board of Directors Current

Chet Borgida - Chet Borgida was elected to the Board of Directors in November 2003. He serves as a member of Warren's audit committee, which he chairs. Mr. Borgida has more than 30 years of domestic and international management experience in auditing and advising retail, distribution and media businesses. He was a partner at Grant Thornton LLP, Warren's independent auditors, from 1977 to 2001. While at Grant Thornton LLP Mr. Borgida had no involvement in the review or preparation of Warren's audited financial statements. From 2001 to 2003, Mr. Borgida was the Senior Vice-President and Chief Financial Officer of Cross Media Marketing Corporation. Recently, he has been serving as the Chief Operating Officer of the Naples Realty Group, Inc. Mr. Borgida is also a director and member of the audit committees of Brand Partners Group, Inc., and Correctional Services Corporation, both Nasdaq listed companies. He was graduated from Hunter College with a Bachelor Degree in Business Science in 1967. He is a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants.

Organization Position Status
Warren Resources, Inc. Chair Current
Warren Resources, Inc. Board of Directors Current
MTS Medication Technologies Board of Directors Current
Grant Thornton LLP partner Former
Hunter College of the City University of New York Bachelor Degree in Business Science Former
BrandPartners Group member Former

David W. Kazarian. Mr. Kazarian has served as a director of MTS since 1988. Mr. Kazarian also serves as a director of Delta RF Technology, Inc., a privately held corporation that manufactures computer components for an international customer base. Prior to its sale in December 1990, Mr. Kazarian and his wife owned and operated Kazarian Pharmacy. Since March 1991, Mr. Kazarian has been the founder and President of Infuserve America, Inc., a firm involved in the home health care business. He is also currently the president of the Kazarian Group Consultants which provides consulting services for certain surgical centers in Pinellas County, Florida and Nursing homes in Connecticut and Massachusetts. Mr. Kazarian received his bachelor s degree in pharmacy from the University of Florida s School of Pharmacy.

Organization Position Status
Delta Rf Technology, Inc. Director Current
MTS Medication Technologies Board of Directors Current
Organization Position Status
Drugmax Inc. CEO Current
Familymeds Group, Inc. Chief Executive Officer Current
Familymeds, Inc. President, Chief Executive Officer, Chairman Current
Familymeds Group, Inc. Chairman Current
Drugmax Inc. Chairman Current
Origin Biomed Inc Board of Directors Current
MTS Medication Technologies Board of Directors Current
Prohealth Physicians Director Current
General Nutrition Centers, Inc. Board of Directors Current
University of the Sciences Board of Directors Current
Familymeds Group, Inc. President Former
Rite Aid Corporation Division Manager Former
Drugmax Inc. Director Former
University of the Sciences in Philadelphia B.S. degree in Pharmacy Former
University Corp. Former
Prohealth Physicians member Former
Organization Position Status
MTS Medication Technologies Board of Directors Current
Organization Position Status
Southeast Capital Ventures Chief Executive Officer Current
Southeast Capital Ventures President Current
Dhs Technologies Chief Financial Officer Current
Reeves Ems, LLC Chief Financial Officer Current
Persystent Technology Corporation Current
Association for Financial Professionals Board of Directors Current
Dhs Technologies Board of Directors Current
MTS Medication Technologies Director Current
Barclays CEO Former
Barclays Cfo Former
GunnAllen Financial Inc. Executive Vice President Former
ABN AMRO Holding N.V. Managing Director Former
ABN AMRO Incorporated Managing Director Former
Financial Professionals Former
Coopers & Lybrand, L.L.P. Former
Pace University MBA Former
New York University Degree In Finance Former
Organization Position Status
Nanobac Pharmaceuticals, Inc. Co-Chairman, Chief Executive Officer and Chief Financial Officer Former
National Sourcing, Inc Chairman, CEO, President Current
Cast Crete Corporation Chairman Current
Nanobac Pharmaceuticals, Inc. Chief Executive and Financial Officer, and Chairman Former
Medtech, Inc. Board of Directors Current
Powercerv Corp Board of Directors Current
Nanobac Pharmaceuticals, Inc. Board of Directors Current
Online Sales Strategies Board of Directors Current
Florida Engineered Construction Products Corp. Chief Executive Officer Former
Florida Engineered Construction Products Corp. President Former
EarthFirst Technologies Incorporated Chairman, President & CEO Former
National Sourcing, Inc Founder Former
Ernst & Young Former
MTS Medication Technologies Director Former
University of South Florida Mba Former
University of South Florida Bachelors Degree in Marketing and Accounting Former
US Energy Initiatives Corp Chairman Former
US Energy Initiatives Corp Board of Directors Former

Executive News

  • MTS Medication Technologies posts profit gain, stops guidance

    Tampa Bay Business Journal - 6/16/09 - View Story

advertisement
Glass Door

Manufacturing Industry Companies

Company Employer Rating
BAE Systems Land and Armaments 3.9
advertisement